Microbix Biosystems Inc. (TSX:MBX)

Revenue by Segment

Financials in millions CAD. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016
Product Sales	18.59M	21.31M	15.16M	19.07M	18.59M
Product Sales Growth	-12.78%	40.51%	-20.49%	2.59%	76.81%
Licensing Fees and Royalties	-	4.09M	1.35M	4.42K	1.91K
Licensing Fees and Royalties Growth	-	202.60%	30440.89%	132.13%	-81.06%
Total	18.59M	25.39M	16.51M	19.08M	18.59M
Total Growth	-26.81%	53.77%	-13.43%	2.60%	76.66%

Revenue by Geography

Financials in millions CAD. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016
North America	11.57M	19.05M	10.83M	13.14M	12.14M
North America Growth	-39.26%	75.84%	-17.58%	8.28%	117.10%
Europe	6.74M	6.01M	5.68M	5.92M	6.45M
Europe Growth	12.00%	5.91%	-4.05%	-8.18%	32.79%
Other Foreign Countries	279.93K	332.61K	3.97K	15.20K	9.67K
Other Foreign Countries Growth	-15.84%	8288.63%	-73.92%	57.24%	-87.88%
Total	18.59M	25.39M	16.51M	19.08M	18.59M
Total Growth	-26.81%	53.77%	-13.43%	2.60%	76.66%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 30, 2026

Data Sources Report a data error